AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Harrow, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SSTRN9
28.44▲ 0.29 (1.03%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
28.15
Day's Range
27.14 – 28.56
52-Week Range
26.96 – 55.00
Volume
852.6K
Avg Volume
627.4K
Share Statistics
Shares Outstanding
Employees
373
Exchange
XNAS
Listed
2007-04-30
Share count as of August 6, 2026

Harrow, Inc. Common Stock (HROW) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Harrow, Inc. Common Stock (HROW)
What is Harrow, Inc. Common Stock's Market Cap?
Harrow, Inc. Common Stock's Market Cap is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's Enterprise Value?
Harrow, Inc. Common Stock's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's Price / Sales?
Harrow, Inc. Common Stock's Price / Sales is 3.9×, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's EV / Revenue?
Harrow, Inc. Common Stock's EV / Revenue is 4.7×, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's EV / EBITDA?
Harrow, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's Revenue (TTM)?
Harrow, Inc. Common Stock's Revenue (TTM) is $275.6M, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's Net Income (TTM)?
Harrow, Inc. Common Stock's Net Income (TTM) is -$37.2M, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's EBITDA?
Harrow, Inc. Common Stock's EBITDA is -$880.0K, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's Diluted EPS (TTM)?
Harrow, Inc. Common Stock's Diluted EPS (TTM) is -0.99, based on as-reported figures from SEC (XBRL) filings.
What is Harrow, Inc. Common Stock's EBITDA Margin?
Harrow, Inc. Common Stock's EBITDA Margin is -0.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · HROWAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Total revenues
YoY growth+10.9%-7.6%+33.3%+45.4%
Cost of sales
Gross profit
% of revenue71.3%61.2%79.3%75.3%
Operating expenses:
Selling, general and administrative
Research and development
Total operating expenses
% of revenue86.9%111.1%61.8%54.7%
(Loss) income from operations
% of revenue-15.6%-50.0%17.5%20.6%
Interest expense, net
Other (expense) income, net—
(Loss) income before income taxes
Income tax expense——
Net (loss) income
% of revenue-24.4%-62.4%7.4%1.4%
Basic net (loss) income per share of common stock (in dollars per share)
Diluted net (loss) income per share of common stock (in dollars per share)